HEADER TRANSFERASE 05-JUL-05 2A7Q TITLE CRYSTAL STRUCTURE OF HUMAN DCK COMPLEXED WITH CLOFARABINE AND ADP COMPND MOL_ID: 1; COMPND 2 MOLECULE: DEOXYCYTIDINE KINASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: DCK; COMPND 5 EC: 2.7.1.74; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DCK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS ALPHA/BETA PARALLEL BETA-SHEET OF 5 STRANDS, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.ZHANG,J.A.SECRIST III,S.E.EALICK REVDAT 4 23-AUG-23 2A7Q 1 REMARK SEQADV LINK REVDAT 3 13-JUL-11 2A7Q 1 VERSN REVDAT 2 24-FEB-09 2A7Q 1 VERSN REVDAT 1 24-JAN-06 2A7Q 0 JRNL AUTH Y.ZHANG,J.A.SECRIST,S.E.EALICK JRNL TITL THE STRUCTURE OF HUMAN DEOXYCYTIDINE KINASE IN COMPLEX WITH JRNL TITL 2 CLOFARABINE REVEALS KEY INTERACTIONS FOR PRODRUG ACTIVATION. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 62 133 2006 JRNL REFN ISSN 0907-4449 JRNL PMID 16421443 JRNL DOI 10.1107/S0907444905034293 REMARK 2 REMARK 2 RESOLUTION. 2.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.49 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 462177.470 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 88.3 REMARK 3 NUMBER OF REFLECTIONS : 9237 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.200 REMARK 3 FREE R VALUE TEST SET COUNT : 755 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.71 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 53.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 842 REMARK 3 BIN R VALUE (WORKING SET) : 0.4000 REMARK 3 BIN FREE R VALUE : 0.4470 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 68 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.054 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1875 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 49 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 72.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 17.32000 REMARK 3 B22 (A**2) : 17.32000 REMARK 3 B33 (A**2) : -34.64000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM SIGMAA (A) : 0.50 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.50 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.64 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.820 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.040 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.760 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.510 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.320 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 62.42 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ADP_PARAM.TXT REMARK 3 PARAMETER FILE 4 : CFA_PRODRG.PARAM REMARK 3 PARAMETER FILE 5 : ION.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 3 : ADP_TOP.TXT REMARK 3 TOPOLOGY FILE 4 : CFA_PRODRG.TOP REMARK 3 TOPOLOGY FILE 5 : ION.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2A7Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JUL-05. REMARK 100 THE DEPOSITION ID IS D_1000033592. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-MAR-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : SILICON REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9726 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.550 REMARK 200 RESOLUTION RANGE LOW (A) : 500.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.3 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04900 REMARK 200 FOR THE DATA SET : 35.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 54.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.16100 REMARK 200 FOR SHELL : 6.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1P61 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM CITRATE, HEPES, PH 7.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 46.83450 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 40.07250 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 40.07250 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 70.25175 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 40.07250 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 40.07250 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 23.41725 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 40.07250 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 40.07250 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 70.25175 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 40.07250 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 40.07250 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 23.41725 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 46.83450 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A DIMER WITH THE SECOND MONOMER REMARK 300 GENERATED BY THE OPERATION: -Y, -X, -Z+1/2 REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 5380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -50.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 80.14500 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 80.14500 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 46.83450 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 THR A 3 REMARK 465 PRO A 4 REMARK 465 PRO A 5 REMARK 465 LYS A 6 REMARK 465 ARG A 7 REMARK 465 SER A 8 REMARK 465 CYS A 9 REMARK 465 PRO A 10 REMARK 465 SER A 11 REMARK 465 PHE A 12 REMARK 465 SER A 13 REMARK 465 ALA A 14 REMARK 465 SER A 15 REMARK 465 SER A 16 REMARK 465 GLU A 17 REMARK 465 GLY A 18 REMARK 465 THR A 19 REMARK 465 GLN A 65 REMARK 465 ASP A 66 REMARK 465 GLU A 67 REMARK 465 PHE A 68 REMARK 465 GLU A 69 REMARK 465 GLU A 70 REMARK 465 LEU A 71 REMARK 465 THR A 72 REMARK 465 MET A 73 REMARK 465 SER A 74 REMARK 465 GLN A 75 REMARK 465 LYS A 76 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 46 CG CD OE1 OE2 REMARK 470 ASN A 113 CG OD1 ND2 REMARK 470 LYS A 115 CG CD CE NZ REMARK 470 LYS A 117 CG CD CE NZ REMARK 470 GLU A 120 CG CD OE1 OE2 REMARK 470 LYS A 121 CG CD CE NZ REMARK 470 GLN A 168 CG CD OE1 NE2 REMARK 470 GLU A 230 CG CD OE1 OE2 REMARK 470 GLU A 240 CG CD OE1 OE2 REMARK 470 GLU A 247 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 45 128.33 -176.71 REMARK 500 PRO A 54 49.72 -67.17 REMARK 500 VAL A 61 108.64 -52.51 REMARK 500 LYS A 88 65.60 -162.42 REMARK 500 LEU A 112 35.94 -95.18 REMARK 500 ASN A 113 28.62 -160.08 REMARK 500 LYS A 121 58.75 -116.26 REMARK 500 ARG A 128 168.10 72.37 REMARK 500 GLN A 165 -107.26 -82.38 REMARK 500 LEU A 217 -72.68 -100.21 REMARK 500 ASP A 244 -62.96 -93.19 REMARK 500 LYS A 245 -6.75 -53.74 REMARK 500 GLU A 255 -72.01 -50.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 300 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 127 OE1 REMARK 620 2 ADP A 301 O3B 124.5 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CFB A 328 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1P5Z RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH CYTARABINE AND ADP REMARK 900 RELATED ID: 1P60 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH 2'-DEOXYCYTIDINE AND ADP, SPACE REMARK 900 GROUP C2221 REMARK 900 RELATED ID: 1P61 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH 2'-DEOXYCYTIDINE AND ADP, SPACE REMARK 900 GROUP P43212 REMARK 900 RELATED ID: 1P62 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH GEMCITABINE AND ADP DBREF 2A7Q A 1 260 UNP P27707 DCK_HUMAN 1 260 SEQADV 2A7Q GLY A -2 UNP P27707 CLONING ARTIFACT SEQADV 2A7Q SER A -1 UNP P27707 CLONING ARTIFACT SEQADV 2A7Q HIS A 0 UNP P27707 CLONING ARTIFACT SEQRES 1 A 263 GLY SER HIS MET ALA THR PRO PRO LYS ARG SER CYS PRO SEQRES 2 A 263 SER PHE SER ALA SER SER GLU GLY THR ARG ILE LYS LYS SEQRES 3 A 263 ILE SER ILE GLU GLY ASN ILE ALA ALA GLY LYS SER THR SEQRES 4 A 263 PHE VAL ASN ILE LEU LYS GLN LEU CYS GLU ASP TRP GLU SEQRES 5 A 263 VAL VAL PRO GLU PRO VAL ALA ARG TRP CYS ASN VAL GLN SEQRES 6 A 263 SER THR GLN ASP GLU PHE GLU GLU LEU THR MET SER GLN SEQRES 7 A 263 LYS ASN GLY GLY ASN VAL LEU GLN MET MET TYR GLU LYS SEQRES 8 A 263 PRO GLU ARG TRP SER PHE THR PHE GLN THR TYR ALA CYS SEQRES 9 A 263 LEU SER ARG ILE ARG ALA GLN LEU ALA SER LEU ASN GLY SEQRES 10 A 263 LYS LEU LYS ASP ALA GLU LYS PRO VAL LEU PHE PHE GLU SEQRES 11 A 263 ARG SER VAL TYR SER ASP ARG TYR ILE PHE ALA SER ASN SEQRES 12 A 263 LEU TYR GLU SER GLU CYS MET ASN GLU THR GLU TRP THR SEQRES 13 A 263 ILE TYR GLN ASP TRP HIS ASP TRP MET ASN ASN GLN PHE SEQRES 14 A 263 GLY GLN SER LEU GLU LEU ASP GLY ILE ILE TYR LEU GLN SEQRES 15 A 263 ALA THR PRO GLU THR CYS LEU HIS ARG ILE TYR LEU ARG SEQRES 16 A 263 GLY ARG ASN GLU GLU GLN GLY ILE PRO LEU GLU TYR LEU SEQRES 17 A 263 GLU LYS LEU HIS TYR LYS HIS GLU SER TRP LEU LEU HIS SEQRES 18 A 263 ARG THR LEU LYS THR ASN PHE ASP TYR LEU GLN GLU VAL SEQRES 19 A 263 PRO ILE LEU THR LEU ASP VAL ASN GLU ASP PHE LYS ASP SEQRES 20 A 263 LYS TYR GLU SER LEU VAL GLU LYS VAL LYS GLU PHE LEU SEQRES 21 A 263 SER THR LEU HET MG A 300 1 HET ADP A 301 27 HET CFB A 328 20 HETNAM MG MAGNESIUM ION HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETNAM CFB 2-CHLORO-9-(2-DEOXY-2-FLUORO-B -D-ARABINOFURANOSYL)-9H- HETNAM 2 CFB PURIN-6-AMINE HETSYN CFB CLOFARABINE FORMUL 2 MG MG 2+ FORMUL 3 ADP C10 H15 N5 O10 P2 FORMUL 4 CFB C10 H11 CL F N5 O3 FORMUL 5 HOH *49(H2 O) HELIX 1 1 GLY A 33 ASN A 39 1 7 HELIX 2 2 ILE A 40 CYS A 45 5 6 HELIX 3 3 VAL A 55 ASN A 60 1 6 HELIX 4 4 ASN A 80 LYS A 88 1 9 HELIX 5 5 LYS A 88 SER A 111 1 24 HELIX 6 6 LEU A 112 ALA A 119 5 8 HELIX 7 7 SER A 129 ILE A 136 1 8 HELIX 8 8 ILE A 136 SER A 144 1 9 HELIX 9 9 ASN A 148 GLN A 165 1 18 HELIX 10 10 GLY A 167 GLU A 171 5 5 HELIX 11 11 THR A 181 GLY A 193 1 13 HELIX 12 12 ASN A 195 ILE A 200 5 6 HELIX 13 13 PRO A 201 LEU A 217 1 17 HELIX 14 14 ASP A 226 VAL A 231 1 6 HELIX 15 15 ASP A 241 THR A 259 1 19 SHEET 1 A 5 TRP A 48 VAL A 51 0 SHEET 2 A 5 VAL A 123 GLU A 127 1 O PHE A 125 N GLU A 49 SHEET 3 A 5 LYS A 22 GLY A 28 1 N LYS A 22 O LEU A 124 SHEET 4 A 5 GLY A 174 GLN A 179 1 O LEU A 178 N GLU A 27 SHEET 5 A 5 ILE A 233 ASP A 237 1 O LEU A 234 N ILE A 175 LINK OE1 GLU A 127 MG MG A 300 1555 1555 2.56 LINK MG MG A 300 O3B ADP A 301 1555 1555 2.85 SITE 1 AC1 4 SER A 35 GLU A 53 GLU A 127 ADP A 301 SITE 1 AC2 20 ASN A 29 ALA A 31 ALA A 32 GLY A 33 SITE 2 AC2 20 LYS A 34 SER A 35 THR A 36 ARG A 188 SITE 3 AC2 20 TYR A 210 GLU A 213 LEU A 217 HIS A 218 SITE 4 AC2 20 GLU A 240 ASP A 241 PHE A 242 MG A 300 SITE 5 AC2 20 HOH A 335 HOH A 346 HOH A 352 HOH A 371 SITE 1 AC3 16 ILE A 30 GLU A 53 TRP A 58 MET A 85 SITE 2 AC3 16 TYR A 86 PHE A 96 GLN A 97 ARG A 104 SITE 3 AC3 16 ARG A 128 ASP A 133 PHE A 137 LEU A 141 SITE 4 AC3 16 GLU A 197 TYR A 204 HOH A 335 HOH A 368 CRYST1 80.145 80.145 93.669 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012477 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012477 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010676 0.00000